StockData

Encore Capital vs PRA

ECPG and PRAA side by side, both in non-depository credit institutions. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ECPG and PRAA compare

Encore Capital is the larger company, worth 5.2 times as much as PRA ($2.3B against $446M).

On earnings, PRA is cheaper: it trades at 2.9× trailing earnings, against 7.0× for Encore Capital.

Encore Capital grew revenue faster over the last twelve months (27.2% versus 12.5% for PRA).

Encore Capital keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with 12.1% at PRA.

PRA scores higher on the StockData Score (13 against 11 for Encore Capital), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricECPGPRAA
Size and price
Market cap$2.3B$446M
Share price$109.49$11.84
Change, 1 year126%−25.8%
Change, 5 years85.8%−72.5%
Beta (5Y)0.831.01
Employees7,3502,615
StockData Score
Total score1113 (better)
Valuation score56 (better)
Growth score3 (better)0
Performance score33
Health score04 (better)
Dividend score00
Valuation
P/E7.0×2.9× (better)
P/S1.2×0.3× (better)
P/B–0.4×
EV/EBITDA2.7×0.8× (better)
P/FCF15.3×–
PEG0.52–
FCF yield6.5% (better)−11.0%
Fair value$149.07$54.97
Margin of safety26.6%78.5% (better)
Growth
Revenue growth (TTM)27.2% (better)12.5%
Revenue growth, 5Y average3.3% (better)2.4%
EPS growth, 5Y average10.3%–
Profitability
Operating margin39.0% (better)35.8%
Net margin17.7% (better)12.1%
FCF margin7.6% (better)−3.8%
Return on equity–15.8%
Return on invested capital–42.4%
Financial health
Debt / equity–0.00
Interest coverage2.6×–
Altman Z-score1.40 (better)0.97
Piotroski F-score6 (better)3
Dividends and buybacks
Buyback yield–6.7%
Shareholder yield0.00%6.7% (better)
Ownership
Held by institutions105%96.3%
Held by insiders5.2%4.1%
Insider net buying, 12 months−$3.0M$0 (better)
Short interest, % of float4.2%2.2%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.